An invention relates to novel non-pathogenic gram-negativ bacteria of Betaproteobacteria class, Neisseraceae subfamily, and bacterial extracts received from bacterial suspensions, composition received by usage of said bacteria, and usage thereat inflammatory disorders treatment and/or prevention.